September 22, 2020 – “The Race for a Coronavirus Vaccine: The Intersection of Science and IP Policy” (Morningside IP and IPWatchdog) – 12:00 pm (ET) September 22, 2020 – “Plausibility at the EPO – Exploring the Legacy of Dasatinib” (Mathys & Squire) – 6:00 to 7:00 pm (GMT Summer Time); 11:00 am to 12:00 pm (ET) September 23-24, 2020 – Program on Promoting Innovation and Supporting Pro-competitive Collaborations in Life Science Sector (U.S. Patent and Trademark Office and Department of Justice) – 1:00 to 5:20 pm ET September 23-24, 2020 – Summit on Biosimilars: Legal, Regulatory, and Commercial Strategies for…
